Alta Partners Files Schedule 13G for 1.94M Envoy Medical Shares

Rhea-AI Filing Summary

Alta Partners LLC filed a Schedule 13G reporting beneficial ownership of 1,944,139 shares of Envoy Medical, Inc. Class A common stock (shares issuable upon exercise of warrants), representing 8.25% of the class. Alta Partners reports sole voting and dispositive power over these shares and certifies the position was acquired and is held in the ordinary course of business and not for the purpose of changing or influencing control of the issuer.

Positive

• Material disclosure of a >5% position (1,944,139 shares, 8.25%) providing transparency to the market
• Sole voting and dispositive power reported for all shares, clarifying who controls votes and disposition
• Certification that the shares were acquired in the ordinary course and not to change control

Negative

• None.

Insights

Securities Analyst

TL;DR: A significant disclosure: Alta Partners reports an >5% warrant-derived stake and sole control of votes and disposition.

Alta Partners' filing shows a material equity position in Envoy Medical equal to 8.25% of Class A stock, derived from shares issuable on exercise of warrants. The filer asserts sole voting and dispositive power, which means Alta can direct voting and disposition of these shares if exercised. The certification that the position is not intended to change control is a standard compliance statement; it limits but does not eliminate governance implications if warrants are exercised and shares are used actively.

Corporate Governance Expert

TL;DR: Ownership is material for investors and governance monitoring but the filer disclaims control intent.

The reported 8.25% stake is above the 5% Schedule 13G threshold, triggering public disclosure requirements and investor scrutiny. Sole voting and dispositive power over 1,944,139 shares gives Alta Partners practical influence if the warrants convert to voting shares. The explicit certification that the holdings are not intended to affect control reduces immediate takeover concerns, yet this position warrants monitoring for any future Form 13D amendments or changes in intent.

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

Envoy Medical, Inc.

(Name of Issuer)

Class A Common Stock

(Title of Class of Securities)

29415V117

(CUSIP Number)

08/20/2025

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

SCHEDULE 13G

CUSIP No. 29415V117

1

Names of Reporting Persons

Alta Partners LLC

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

NEW YORK

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 1,944,139.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 1,944,139.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

1,944,139.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

8.3 %

12

Type of Reporting Person (See Instructions)

OO

SCHEDULE 13G

Item 1.
(a)	Name of issuer: Envoy Medical, Inc.
(b)	Address of issuer's principal executive offices: 4875 WHITE BEAR PARKWAY, WHITE BEAR LAKE, MINNESOTA, 55110.
Item 2.
(a)	Name of person filing: Alta Partners LLC
(b)	Address or principal business office or, if none, residence: 1205 Franklin Avenue Garden City, New York 11530
(c)	Citizenship: New York Limited Liability Company
(d)	Title of class of securities: Class A Common Stock
(e)	CUSIP No.: 29415V117
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: 1,944,139 shares of Class A common stock, representing shares issuable upon exercise of warrants
(b)	Percent of class: 8.25%
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: 1,944,139 shares of Class A common stock
	(ii) Shared power to vote or to direct the vote: 0 shares of Class A common stock
	(iii) Sole power to dispose or to direct the disposition of: 1,944,139 shares of Class A common stock
	(iv) Shared power to dispose or to direct the disposition of: 0 shares of Class A common stock
Item 5.	Ownership of 5 Percent or Less of a Class.
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11. By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Alta Partners LLC

Signature:	/s/ Steven Cohen
Name/Title:	Steven Cohen, Managing Member
Date:	08/21/2025

FAQ

What stake does Alta Partners LLC report in Envoy Medical (COCH)?

Alta Partners reports beneficial ownership of 1,944,139 shares, representing 8.25% of Envoy Medical Class A common stock.

Are the reported shares currently outstanding common stock or related to warrants?

The filing states the amount represents shares issuable upon exercise of warrants.

Does Alta Partners assert voting or dispositive control over the reported shares?

Yes. The filer reports sole voting power and sole dispositive power for all 1,944,139 shares.

Does Alta Partners intend to influence control of Envoy Medical (COCH)?

The filing includes a certification that the securities were not acquired and are not held for the purpose of changing or influencing control of the issuer.

When was the Schedule 13G signed and by whom?

The filing is signed by Steven Cohen, Managing Member of Alta Partners LLC on 08/21/2025.